Kibow Biotech celebrates 25th anniversary as drug trials commence
Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.
Archives for October 4, 2022
Merck KGaA invests in France, boosts production capacity for mAbs
Merck KGaA has opened a facility to support the delivery of its new Millipore CTDMO services at its site in Martillac, France.
US CDMO developments: Genezen further expands lentiviral and retroviral vector production site, Wheeler Bio closes Series A round
Genezen has completed another expansion phase at its viral vector process development and cGMP vector production facility in Fishers, Indiana.
EMA pilot to provide regulatory support to selected ATMP developers
The European Medicines Agency (EMA) will provide up to five selected advanced therapy medicinal products (ATMPs) with enhanced regulatory support - and in the process hopes to learn how to improve the regulatory processes for other ATMP drugs in the future.
AstraZeneca’s Alexion acquires genomic medicine company
Alexion, AstraZeneca Rare Disease will acquire LogicBio Therapeutics, an American genomic medicine company.